{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:03:01Z","timestamp":1792875781519,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":1003,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Aging Research & Lifestyle"],"published-print":{"date-parts":[[2022]]},"DOI":"10.14283\/jarlife.2022.7","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T05:07:41Z","timestamp":1668488861000},"page":"38-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["MODELLING THE PAN-EUROPEAN ECONOMIC BURDEN OF ALZHEIMER'S DISEASE"],"prefix":"10.1016","volume":"11","author":[{"given":"R.","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Urbich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Br\u00e4nnvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gianinazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.H.","family":"El-Hayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jarlife.2022.7_bib1","first-page":"1","article-title":"What Matters to Patients with Alzheimer's Disease and Their Care Partners? Implications for Understanding the Value of Future Interventions","author":"Jessen","year":"2022","journal-title":"J Prev Alzheimer's Dis"},{"key":"10.14283\/jarlife.2022.7_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13607863.2014.915923","article-title":"Quality of life in dementia: A systematically conducted narrative review of dementia-specific measurement scales","volume":"19","author":"Bowling","year":"2015","journal-title":"Aging Ment Heal"},{"key":"10.14283\/jarlife.2022.7_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2014.03.001","article-title":"Dependence in Alzheimer's disease and service use costs, quality of life, and caregiver burden: The DADE study","volume":"11","author":"Jones","year":"2015","journal-title":"Alzheimer's Dement"},{"key":"10.14283\/jarlife.2022.7_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and Future Treatments in Alzheimer Disease: An Update","author":"Yiannopoulou","year":"2020","journal-title":"J Cent Nerv Syst Dis"},{"key":"10.14283\/jarlife.2022.7_bib6","first-page":"1","article-title":"Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis","author":"Liss","year":"2021","journal-title":"J Intern Med"},{"issue":"10248","key":"10.14283\/jarlife.2022.7_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"10284","key":"10.14283\/jarlife.2022.7_bib8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.14283\/jarlife.2022.7_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/alz.12068","article-title":"2020 Alzheimer's disease facts and figures","volume":"16","author":"Alzheimer's Association","year":"2020","journal-title":"Alzheimer's Dement"},{"key":"10.14283\/jarlife.2022.7_bib10","article-title":"Alzheimer's disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimer's Dement Transl Res Clin Interv"},{"key":"10.14283\/jarlife.2022.7_bib11","author":"Alzheimer's Association"},{"key":"10.14283\/jarlife.2022.7_bib12","author":"Prince"},{"key":"10.14283\/jarlife.2022.7_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","article-title":"The worldwide costs of dementia 2015 and comparisons with 2010","volume":"13","author":"Wimo","year":"2017","journal-title":"Alzheimer's Dement"},{"key":"10.14283\/jarlife.2022.7_bib14","doi-asserted-by":"crossref","first-page":"e0210958","DOI":"10.1371\/journal.pone.0210958","article-title":"Predictions of Alzheimer's disease treatment and care costs in European countries","volume":"14","author":"Cimler","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.14283\/jarlife.2022.7_bib15","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2666-7568(20)30004-0","article-title":"Effective interventions for potentially modifiable risk factors for late-onset dementia: a costs and cost-effectiveness modelling study","volume":"1","author":"Mukadam","year":"2020","journal-title":"Lancet Heal Longev"},{"key":"10.14283\/jarlife.2022.7_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40120-021-00273-0","article-title":"Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's Disease","volume":"10","author":"Herring","year":"2021","journal-title":"Neurol Ther"},{"key":"10.14283\/jarlife.2022.7_bib17","author":"EuroStat"},{"key":"10.14283\/jarlife.2022.7_bib18","author":"Office for National Statistics"},{"key":"10.14283\/jarlife.2022.7_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"key":"10.14283\/jarlife.2022.7_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dadm.2015.12.002","article-title":"Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)","volume":"2","author":"Knopman","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.14283\/jarlife.2022.7_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/heapol\/czaa073","article-title":"On discount rates for economic evaluations in global health","volume":"35","author":"Haacker","year":"2020","journal-title":"Health Policy Plan"},{"key":"10.14283\/jarlife.2022.7_bib22","author":"DESTATIS"},{"key":"10.14283\/jarlife.2022.7_bib23","author":"INSEE"},{"key":"10.14283\/jarlife.2022.7_bib24","author":"European Central Bank"},{"key":"10.14283\/jarlife.2022.7_bib25","author":"Instituto Nacional de Estad\u00edstica"},{"key":"10.14283\/jarlife.2022.7_bib26","author":"Statistics Sweden"},{"key":"10.14283\/jarlife.2022.7_bib27","author":"Curtis"},{"key":"10.14283\/jarlife.2022.7_bib28","series-title":"Unit Costs of Health and Social Care 2021","author":"Jones","year":"2021"},{"key":"10.14283\/jarlife.2022.7_bib29","author":"Bank of America"},{"key":"10.14283\/jarlife.2022.7_bib30","author":"Bank of England"},{"key":"10.14283\/jarlife.2022.7_bib31","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jalz.2019.05.004","article-title":"Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework","volume":"15","author":"Green","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jarlife.2022.7_bib32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3233\/JAD-191055","article-title":"Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions","volume":"75","author":"Wimo","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jarlife.2022.7_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2174\/1567205015666180119092427","article-title":"Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia","volume":"15","author":"Davis","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"10.14283\/jarlife.2022.7_bib34","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jagp.2016.07.005","article-title":"Mortality in mild cognitive impairment diagnosed with DSM-5 criteria and with petersen's criteria: A 17-year follow-up in a community study","volume":"24","author":"Santab\u00e1rbara","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.14283\/jarlife.2022.7_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000265553","article-title":"Very mild to severe dementia and mortality: A 14-year follow-up - The Odense study","volume":"29","author":"Andersen","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.14283\/jarlife.2022.7_bib36","author":"DESTATIS"},{"key":"10.14283\/jarlife.2022.7_bib38","author":"Instituto Nacional de Estad\u00edstica"},{"key":"10.14283\/jarlife.2022.7_bib39","author":"Institut National d\u2019\u00c9tudes D\u00e9mographiques"},{"key":"10.14283\/jarlife.2022.7_bib40","author":"Office for National Statistics"},{"key":"10.14283\/jarlife.2022.7_bib41","author":"Statistics Sweden"},{"key":"10.14283\/jarlife.2022.7_bib42","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1177\/1471301219837776","article-title":"The economic cost of dementia: A systematic review","volume":"19","author":"Cantarero-Prieto","year":"2020","journal-title":"Dementia"},{"key":"10.14283\/jarlife.2022.7_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-190426","article-title":"Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders","volume":"70","author":"El-Hayek","year":"2019","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.14283\/jarlife.2022.7_bib44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2021.17","article-title":"Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review","volume":"8","author":"Klie\u00df","year":"2021","journal-title":"J Prev Alzheimer's Dis"},{"key":"10.14283\/jarlife.2022.7_bib45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10198-014-0642-0","article-title":"Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain","volume":"16","author":"Darb\u00e0","year":"2015","journal-title":"Eur J Heal Econ"},{"key":"10.14283\/jarlife.2022.7_bib46","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1017\/S1041610217001211","article-title":"Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: Results from the GERAS II observational study","volume":"29","author":"Olazar\u00e1n","year":"2017","journal-title":"Int Psychogeriatrics"},{"issue":"7","key":"10.14283\/jarlife.2022.7_bib47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10198-014-0620-6","article-title":"Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries","volume":"16","author":"W\u00fcbker","year":"2015","journal-title":"Eur J Heal Econ"},{"key":"10.14283\/jarlife.2022.7_bib48","author":"OECD"},{"key":"10.14283\/jarlife.2022.7_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3233\/JAD-191212","article-title":"Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1","volume":"75","author":"Robinson","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jarlife.2022.7_bib50","author":"Prince"},{"key":"10.14283\/jarlife.2022.7_bib51","author":"World Bank"},{"key":"10.14283\/jarlife.2022.7_bib52","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/jgs.14227","article-title":"Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis","volume":"64","author":"Lin","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"10.14283\/jarlife.2022.7_bib53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/jgs.12132","article-title":"Health-Related Resource Use and Costs in Elderly Adults with and without Mild Cognitive Impairment","volume":"61","author":"Zhu","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.14283\/jarlife.2022.7_bib54","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/ene.13043","article-title":"Health, social and economic consequences of dementias: a comparative national cohort study","volume":"23","author":"Frahm-Falkenberg","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.14283\/jarlife.2022.7_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00659-6","article-title":"Assessing what matters most to patients with or at risk for Alzheimer's and care partners: A qualitative study evaluating symptoms, impacts, and outcomes","volume":"12","author":"Dibenedetti","year":"2020","journal-title":"Alzheimer's Res Ther"},{"key":"10.14283\/jarlife.2022.7_bib56","first-page":"231","article-title":"What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review","volume":"11","author":"Tochel","year":"2019","journal-title":"Alzheimer's Dement Diagnosis, Assess Dis Monit"},{"key":"10.14283\/jarlife.2022.7_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0283-5","article-title":"On the path to 2025: Understanding the Alzheimer's disease continuum","volume":"9","author":"Aisen","year":"2017","journal-title":"Alzheimer's Res Ther"},{"key":"10.14283\/jarlife.2022.7_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-016-1960-3","article-title":"Which medical and social decision topics are important after early diagnosis of Alzheimer's Disease from the perspectives of people with Alzheimer's Disease, spouses and professionals?","volume":"9","author":"Bronner","year":"2016","journal-title":"BMC Res Notes"},{"key":"10.14283\/jarlife.2022.7_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13041-019-0448-1","article-title":"Blood-based molecular biomarkers for Alzheimer's disease","volume":"12","author":"Zetterberg","year":"2019","journal-title":"Mol Brain"},{"key":"10.14283\/jarlife.2022.7_bib61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimer's Dement"},{"key":"10.14283\/jarlife.2022.7_bib62","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jalz.2016.12.005","article-title":"Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease","volume":"13","author":"Gustavsson","year":"2017","journal-title":"Alzheimer's Dement"},{"key":"10.14283\/jarlife.2022.7_bib63","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14737167.2020.1822738","article-title":"Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease","volume":"20","author":"Gustavsson","year":"2020","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res"},{"key":"10.14283\/jarlife.2022.7_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jalz.2019.09.087","article-title":"Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube","volume":"16","author":"Janssen","year":"2020","journal-title":"Alzheimer's Dement"}],"container-title":["The Journal of Aging Research & Lifestyle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2534773X24000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2534773X24000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:05:39Z","timestamp":1736503539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2534773X24000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":61,"alternative-id":["S2534773X24000272"],"URL":"https:\/\/doi.org\/10.14283\/jarlife.2022.7","relation":{},"ISSN":["2534-773X"],"issn-type":[{"value":"2534-773X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MODELLING THE PAN-EUROPEAN ECONOMIC BURDEN OF ALZHEIMER'S DISEASE","name":"articletitle","label":"Article Title"},{"value":"The Journal of Aging Research & Lifestyle","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jarlife.2022.7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 \u00a9 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}